Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Saved in:
| Main Authors: | Paola Quaresima, Samuel H. Myers, Basilio Pintaudi, Rosario D’Anna, Michele Morelli, Vittorio Unfer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1569086/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
by: Cesare Aragona, et al.
Published: (2025-03-01) -
Effects Of Metformin And Myo-Inositol In Combination Versus Metformin As Monotherapy On The Metabolic Profile Of Polycystic Ovarian Syndrome Patients With Infertility
by: Hira Ehsan Khattak, et al.
Published: (2024-09-01) -
Effect of myo-inositol and d-chiro-inositol on improving hormonal, metabolic and reproductive parameters in women with polycystic ovary syndrome: A review of studies
by: Aleksandra Ciuła, et al.
Published: (2025-05-01) -
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
by: Nicolas Mendoza, et al.
Published: (2019-08-01) -
Antioxidant and cytokine modulation in PCOS rats protected with probiotics, myo-inositol, and herbal extracts
by: AA Zaki, et al.
Published: (2025-06-01)